DMACDiaMedica Therapeutics Inc.
Earnings
When DiaMedica Therapeutics Inc. reports, what it reported each quarter, and how the stock took the results.
35 quarters. Mar 31, 2018 to Sep 30, 2026. USD.
Next results · Q4 2026Projected
Mar 29, after the close
Mon, Mar 29, 2027in 131 days
Projected from its last 8 releases. The company has not named the day yet.
- Quarter
- Q4 2026 · Ends about Dec 31, 2026
- 10-K window
- Mar 11 – 31
Read against Q4 2025
The same quarter a year earlier, the figures the next ones will be compared with. Thaler holds no estimates.
- Revenue
- —
- Net income
- -$8.74M
- Net income, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q4 2025 n/m
- EPS
- —
- EPS, change from a year earlier: Q3 2021 n/m, Q2 2021 n/m, Q1 2021 n/m, Q3 2020 n/m
Latest results
- Revenue
- —
- —
- Net income
- -$11.31M
- N/M
- EPS
- —
- —
- Revenue
- —
- —
- Net income
- -$10.14M
- N/M
- EPS
- —
- —
- Revenue
- —
- —
- Net income
- -$10.04M
- N/M
- EPS
- —
- —
- Revenue
- —
- —
- Net income
- -$8.74M
- N/M
- EPS
- —
- —
All quarters
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Move | Source trail |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | ||||||||||
| Q3 2026 | Sep 30, 2026 | Nov 12, 2026 · after-hours | Nov 12, 2026 | 43 d | 10-Q | — | — | — | — | |
| Q2 2026 | Jun 30, 2026 | Aug 10, 2026 · after-hours | Aug 10, 2026 | 41 d | 10-Q | — | — | — | +3.3% | |
| Q1 2026 | Mar 31, 2026 | May 6, 2026 · after-hours | May 6, 2026 | 36 d | 10-Q | — | — | — | 0.3% | |
| FY 2025 | ||||||||||
| Q4 2025derived | Dec 31, 2025 | Mar 30, 2026 · after-hours | Mar 30, 2026 | 89 d | 10-K | — | — | — | +1.7% | |
| Q3 2025 | Sep 30, 2025 | Nov 12, 2025 · after-hours | Nov 12, 2025 | 43 d | 10-Q | — | — | — | 13.9% | |
| Q2 2025 | Jun 30, 2025 | Aug 12, 2025 · after-hours | Aug 12, 2025 | 43 d | 10-Q | — | — | — | +15.4% | |
| Q1 2025 | Mar 31, 2025 | May 13, 2025 · after-hours | May 13, 2025 | 43 d | 10-Q | — | — | — | +2.4% | |
| FY 2024 | ||||||||||
| Q4 2024derived | Dec 31, 2024 | Mar 17, 2025 · after-hours | Mar 17, 2025 | 76 d | 10-K | — | — | — | 13.0% | |
| Q3 2024 | Sep 30, 2024 | Nov 13, 2024 · after-hours | Nov 13, 2024 | 44 d | 10-Q | — | — | — | 3.3% | |
| Q2 2024 | Jun 30, 2024 | Aug 7, 2024 · after-hours | Aug 7, 2024 | 38 d | 10-Q | — | — | — | — | |
| Q1 2024 | Mar 31, 2024 | May 8, 2024 · after-hours | May 8, 2024 | 38 d | 10-Q | — | — | — | — | |
| FY 2023 | ||||||||||
| Q4 2023derived | Dec 31, 2023 | Mar 19, 2024 · after-hours | Mar 19, 2024 | 79 d | 10-K | — | — | — | 9.2% | |
| Q3 2023 | Sep 30, 2023 | Nov 13, 2023 · after-hours | Nov 13, 2023 | 44 d | 10-Q | — | — | — | +3.8% | |
| Q2 2023 | Jun 30, 2023 | Aug 14, 2023 · after-hours | Aug 14, 2023 | 45 d | 10-Q | — | — | — | — | |
| Q1 2023 | Mar 31, 2023 | May 15, 2023 · after-hours | May 15, 2023 | 45 d | 10-Q | — | — | — | 10.2% | |
| FY 2022 | ||||||||||
| Q4 2022derived | Dec 31, 2022 | Mar 28, 2023 · after-hours | Mar 28, 2023 | 87 d | 10-K | — | — | — | — | |
| Q3 2022 | Sep 30, 2022 | Nov 9, 2022 · after-hours | Nov 9, 2022 | 40 d | 10-Q | — | — | — | 5.6% | |
| Q2 2022 | Jun 30, 2022 | Aug 10, 2022 · after-hours | Aug 11, 2022 | 42 d | 10-Q | — | — | — | +5.8% | |
| Q1 2022 | Mar 31, 2022 | May 4, 2022 · after-hours | May 4, 2022 | 34 d | 10-Q | — | — | — | +8.6% | |
| FY 2021 | ||||||||||
| Q4 2021derived | Dec 31, 2021 | Mar 14, 2022 · after-hours | Mar 14, 2022 | 73 d | 10-K | — | — | — | — | |
| Q3 2021 | Sep 30, 2021 | Nov 10, 2021 · after-hours | Nov 10, 2021 | 41 d | 10-Q | — | — | -$0.18 | — | |
| Q2 2021 | Jun 30, 2021 | Aug 11, 2021 · after-hours | Aug 11, 2021 | 42 d | 10-Q | — | — | -$0.17 | — | |
| Q1 2021 | Mar 31, 2021 | May 5, 2021 · after-hours | May 5, 2021 | 35 d | 10-Q | — | — | -$0.19 | 10.2% | |
| FY 2020 | ||||||||||
| Q4 2020derived | Dec 31, 2020 | Mar 10, 2021 · after-hours | Mar 10, 2021 | 69 d | 10-K | — | — | — | — | |
| Q3 2020 | Sep 30, 2020 | Nov 4, 2020 · after-hours | Nov 4, 2020 | 35 d | 10-Q | — | — | -$0.19 | 5.7% | |
| Q2 2020 | Jun 30, 2020 | Aug 11, 2020 · after-hours | Aug 11, 2020 | 42 d | 10-Q | — | — | -$0.17 | 0.6% | |
| Q1 2020 | Mar 31, 2020 | May 13, 2020 · after-hours | May 13, 2020 | 43 d | 10-Q | — | — | -$0.19 | — | |
| FY 2019 | ||||||||||
| Q4 2019derived | Dec 31, 2019 | Mar 23, 2020 · after-hours | Mar 23, 2020 | 83 d | 10-K | — | — | — | 4.3% | |
| Q3 2019 | Sep 30, 2019 | Nov 13, 2019 · after-hours | Nov 13, 2019 | 44 d | 10-Q | — | — | -$0.20 | 9.8% | |
| Q2 2019 | Jun 30, 2019 | Aug 13, 2019 · after-hours | Aug 13, 2019 | 44 d | 10-Q | — | — | -$0.21 | — | |
| Q1 2019 | Mar 31, 2019 | May 13, 2019 · after-hours | May 13, 2019 | 43 d | 10-Q | — | — | -$0.27 | — | |
| FY 2018 | ||||||||||
| Q4 2018derived | Dec 31, 2018 | Mar 19, 2019 · after-hours | Mar 19, 2019 | 78 d | 10-K | — | — | — | — | |
| Q3 2018 | Sep 30, 2018 | — | — | — | — | $500.00K | — | -$0.18 | — | |
| Q2 2018 | Jun 30, 2018 | — | — | — | — | — | — | -$0.22 | — | |
| Q1 2018 | Mar 31, 2018 | — | — | — | — | — | — | -$0.10 | — | |
Earlier years, FY 2018 to FY 2023The latest three years
Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Source filings
Provenance
ProvenanceData status and checks
DiaMedica Therapeutics Inc. · CIK 1401040 · Engraved from SEC EDGAR